50% off Premium Yearly

NYSE:KEYS
This summary was created by AI, based on 2 opinions in the last 12 months.
Keysight Technologies Inc. (KEYS-N) is recognized as a leading measurement company, especially noted for its role in the quantum technology sector. With its strong focus on making inferences within the middle part of the quantum stack, it stands out among firms testing chips prior to market launch. Analysts have set an optimistic 12-month price target at $403, despite the stock currently appearing expensive. Expert recommendations suggest a phased buying approach at current levels of around $340 and $320. In addition to its quantum capabilities, Keysight has assets in the natural gas sector, positioning it to benefit from the burgeoning AI infrastructure market in the U.S., particularly through its measurement services for pipeline systems.
Keysight Technologies Inc. is a American stock, trading under the symbol KEYS (previously KEYS-N on Stockchase) on the New York Stock Exchange (KEYS). It is usually referred to as NYSE:KEYS or KEYS
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on KEYS (previously KEYS-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is WAIT. Read the latest stock experts' ratings for Keysight Technologies Inc..
Keysight Technologies Inc. was recommended as a Top Pick by Gordon Reid on 2021-07-14. Read the latest stock experts ratings for Keysight Technologies Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Keysight Technologies Inc..
Keysight Technologies Inc. is followed by 62 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-15, Keysight Technologies Inc. (KEYS) stock closed at a price of $356.94.
On the platform part of quantum -- middle part of the stack -- helps quantum make inferences. A measurement company, so it's one of the major players testing chips before they get rolled out.
(Analysts’ price target is $318.62)His 12-month price target is $403. May seem pricey, but keep it on your radar. Buy in thirds here, at $340, and at $320. No dividend.